Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Systematic review with meta-analysis: risk of post-operative complications associated with pre-operative exposure to anti-tumour necrosis factor agents for Crohn's disease.

Lin YS, Cheng SW, Wang YH, Chen KH, Fang CJ, Chen C.

Aliment Pharmacol Ther. 2019 Apr;49(8):966-977. doi: 10.1111/apt.15184. Epub 2019 Mar 12. Review.

PMID:
30864199
2.

The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.

Rosenfeld G, Qian H, Bressler B.

J Crohns Colitis. 2013 Dec;7(11):868-77. doi: 10.1016/j.crohns.2013.01.019. Epub 2013 Mar 5. Review.

3.

Post-operative abdominal complications in Crohn's disease in the biological era: Systematic review and meta-analysis.

Waterland P, Athanasiou T, Patel H.

World J Gastrointest Surg. 2016 Mar 27;8(3):274-83. doi: 10.4240/wjgs.v8.i3.274.

4.

Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.

Nørgård BM, Nielsen J, Qvist N, Gradel KO, de Muckadell OB, Kjeldsen J.

Aliment Pharmacol Ther. 2013 Jan;37(2):214-24. doi: 10.1111/apt.12159. Epub 2012 Nov 28.

5.
6.

Pre-operative total parenteral nutrition improves post-operative outcomes in a subset of Crohn's disease patients undergoing major abdominal surgery.

Ayoub F, Kamel AY, Ouni A, Chaudhry N, Ader Y, Tan S, Iqbal A, Zimmermann EM, Glover SC.

Gastroenterol Rep (Oxf). 2019 Apr;7(2):107-114. doi: 10.1093/gastro/goy033. Epub 2018 Sep 4.

7.

Perioperative blood transfusion is associated with post-operative infectious complications in patients with Crohn's disease.

Lan N, Stocchi L, Li Y, Shen B.

Gastroenterol Rep (Oxf). 2018 May;6(2):114-121. doi: 10.1093/gastro/gox023. Epub 2017 May 30.

8.

Anti-TNF and postoperative complications in abdominal Crohn's disease surgery.

Yamamoto T, Teixeira FV, Saad-Hossne R, Kotze PG, Danese S.

Curr Drug Targets. 2019 Apr 4. doi: 10.2174/1389450120666190404144048. [Epub ahead of print]

PMID:
30947671
9.

Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis.

Kopylov U, Ben-Horin S, Zmora O, Eliakim R, Katz LH.

Inflamm Bowel Dis. 2012 Dec;18(12):2404-13. doi: 10.1002/ibd.22954. Epub 2012 Mar 29. Review.

PMID:
22467533
10.

Systematic review: The use of thiopurines or anti-TNF in post-operative Crohn's disease maintenance--progress and prospects.

Jones GR, Kennedy NA, Lees CW, Arnott ID, Satsangi J.

Aliment Pharmacol Ther. 2014 Jun;39(11):1253-65. doi: 10.1111/apt.12743. Epub 2014 Apr 16. Review.

11.

The effect of pre-operative optimization on post-operative outcome in Crohn's disease resections.

El-Hussuna A, Iesalnieks I, Horesh N, Hadi S, Dreznik Y, Zmora O.

Int J Colorectal Dis. 2017 Jan;32(1):49-56. doi: 10.1007/s00384-016-2655-x. Epub 2016 Oct 26.

PMID:
27785551
12.

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.

Dretzke J, Edlin R, Round J, Connock M, Hulme C, Czeczot J, Fry-Smith A, McCabe C, Meads C.

Health Technol Assess. 2011 Feb;15(6):1-244. doi: 10.3310/hta15060. Review.

13.

Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study.

Nørgård BM, Nielsen J, Qvist N, Gradel KO, de Muckadell OB, Kjeldsen J.

Aliment Pharmacol Ther. 2012 Jun;35(11):1301-9. doi: 10.1111/j.1365-2036.2012.05099.x. Epub 2012 Apr 16.

14.

Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn's disease.

Ahmed Ali U, Martin ST, Rao AD, Kiran RP.

Dis Colon Rectum. 2014 May;57(5):663-74. doi: 10.1097/DCR.0000000000000099. Review.

PMID:
24819109
15.

Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease.

Ali T, Yun L, Rubin DT.

World J Gastroenterol. 2012 Jan 21;18(3):197-204. doi: 10.3748/wjg.v18.i3.197. Review.

16.

Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.

Syed A, Cross RK, Flasar MH.

Am J Gastroenterol. 2013 Apr;108(4):583-93. doi: 10.1038/ajg.2012.464. Epub 2013 Mar 12.

PMID:
23481144
17.

Preoperative infliximab use and postoperative complications in Crohn's disease: a systematic review and meta-analysis.

Yang ZP, Hong L, Wu Q, Wu KC, Fan DM.

Int J Surg. 2014;12(3):224-30. doi: 10.1016/j.ijsu.2013.12.015. Epub 2014 Jan 3. Review.

18.

Systematic review and network meta-analysis Medical therapies to prevent recurrence of post-operative Crohn's disease.

Burr NE, Hall B, Hamlin PJ, Selinger CP, Ford AC, O'Connor A.

J Crohns Colitis. 2018 Dec 14. doi: 10.1093/ecco-jcc/jjy216. [Epub ahead of print]

PMID:
30561586
19.

Phenotypic features of Crohn's disease associated with failure of medical treatment.

Moran GW, Dubeau MF, Kaplan GG, Yang H, Seow CH, Fedorak RN, Dieleman LA, Barkema HW, Ghosh S, Panaccione R; Alberta Inflammatory Bowel Disease Consortium.

Clin Gastroenterol Hepatol. 2014 Mar;12(3):434-42.e1. doi: 10.1016/j.cgh.2013.08.026. Epub 2013 Aug 24.

PMID:
23978351
20.

Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease.

Narula N, Charleton D, Marshall JK.

Aliment Pharmacol Ther. 2013 Jun;37(11):1057-64. doi: 10.1111/apt.12313. Epub 2013 Apr 14. Review.

Supplemental Content

Support Center